Patient Data Market
We are a us based investment firm that is looking to talk to someone who has experience selling patient data to pharmaceutical companies and the relevant regulatory hurdles/approvals if any. Ideally we wish to speak with senior level people within the space that can help us better understand packaging of patient data to sell to pharma companies. Someone who collects data for a big pharma company (pfizer, gsk, etc.) for a prescription medicine. Ideally the person is a senior brand manager and analyzes data from rfp’s they’ve put out.
1) have you packaged and sold patient data to pharma companies / other companies?
2) have you used data from emr’s?
3) what kind of patient data have you dealt with in the past?
Please include your answers to our screening questions along with any other useful related details. Thank you.+undefined Other Responses
Management consultant working with major healthcare it client willing to pay significantly for 60 minute informational interview with individuals that meet the following criteria:
type of organization and role/title:
non-it – ceo/cmo
it – cio, vp of it infrastructure/systems
radiology department –
general radiologist – collects and reads images
general radiologist – only reads images
pacs/ris admin or director
interventional cardiologist (e.G. Cath lab)
non-interventional cardiologist (e.G. Echo lab)
cvis/cpacs admin or director
standalone imaging center
ceo or cio
diagnostic imaging experts
diagnostic imaging industry analyst (e.G. Healthcare it, with focus on pacs/vna/ris/cvis markets)
radiology or cardiology expert (e.G. Professors or industry think tanks, such as acr)
- these experts should :
standalone diagnostic imaging centers or practices (e.G. Imaging centers not located within a hospital)
contract diagnostic imaging centers (e.G. Radiology practice within a hospital)
owned/employed by hospital system (e.G. Radiology department within a hospital)
- all interviewees should have the following characteristics:
experience with and/or strong knowledge of different types of diagnostic imaging modalities (e.G. Pet, ct, etc.) and/or systems (e.G. Pacs, ris, cvis, vna)
broad understanding of u.S. Healthcare system trends related to diagnostic imaging in acute and ambulatory settings
broad perspective on the value of diagnostic imaging within a health system (e.G. Total cost of care)
strong view of emerging value-based reimbursement models in the u.S. (e.G. Capitation, bundled payment, etc.) and its impact on diagnostic imaging
reach out if you match most or all of criteria (negotiable if good fit for what we're looking for).+20 Other Responses